The federal court overseeing thousands of Abilify gambling lawsuits has chosen six cases for trials that will be convened during the summer of 2019. According to an Order issued in the U.S. District Court, Northern District of Florida, on December … Continue reading
Heart burn drugs like Nexium, Prilosec, and PrevAcid, have been linked to serious proton pump inhibitor side effects, including kidney failure and other renal complications. Now two new studies are highlighting potential risks to children and patients prone to hip … Continue reading
The U.S. Food & Drug Administration (FDA) has issued a Warning Letter to the Chinese manufacturer behind a global recall of contaminated valsartan tablets. Cancer-Causing Chemical Detected in Valsartan API Valsartan is the generic name for Diovan, a prescription medication … Continue reading
The judge overseeing the first federal trial of a Monsanto Roundup lawsuit has agreed to screen jurors with knowledge of a landmark verdict awarded earlier this year in a similar state court case. According to Law.com, attorneys for Bayer sought … Continue reading
As patients in the United States continue to file MRI contrast dye lawsuits, a new study suggests artificial intelligence could be used to reduce risks potentially associated with gadolinium retention. Gadolinium MRI Contrast Dyes Gadolinium is a toxic heavy metal … Continue reading
A federal judge in Michigan has denied Medtronic’s Inc.’s motion to dismiss fraud claims asserted in a lawsuit involving its PrimeAdvanced spinal-cord stimulator implant. Spinal-Cord Stimulator Injury Allegations According to a complaint filed in the U.S. District Court, Eastern District … Continue reading
A new Viberzi lawsuit filed in Pennsylvania claims Allergan USA withheld important safety information from patients and doctors in the United States. Specifically, the fact that Viberzi increases the risk for pancreatitis in patients without a gallbladder Viberzi Lawsuit Allegations … Continue reading
Yet another HIV drug lawsuit claims Gilead maximized profits by deliberately delaying the development tenofovir alafenamide (TAF), despite a better safety profile compared to tenofovir disoproxil fumarate (TDF). Gilead Monopolizes HIV anti-viral Drug Market The U.S. Food & Drug Administration … Continue reading